Xeraya Capital is a venture capital and private equity firm headquartered in Kuala Lumpur, Malaysia. It was founded it 2012 by the Khazanah Nasional Berhad, the sovereign wealth fund of the Malaysia. The firm invests in the life sciences industry. It has invested in medical technologies, biotechnology, pharmaceuticals, and biorenewable fuel resources.
In 2018, Xeraya Capital signed the United Nations sponsored Principals for Responsible Investment, which aims to create a more sustainable global financial system. The firm as a whole aims to improve the lives of Southeast Asians and humanity through its investing.
An industrial biotechnology company using a bioprocessing platform to produce chemical products.
A renewable chemicals and advanced biofuels company.
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
Congenica clinical decision support software is the world's leading solution for the analysis of genomic data, enabling healthcare professionals globally.
Imago BiosSciences is a clinical-stage therapeutics company developing treatments for malignant and life-threatening diseases for bone marrow.
A biotechnology company the develops tools for detection of microbial contamination
Gevo is an Englewood, California-based producer of biofuels and cost-effective fossil fuel alternatives.